Healthcare - Biotechnology - NASDAQ - US
$ 15.66
-5.49 %
$ 26 M
Market Cap
-2.33
P/E
Price Target
Average
104.34%
Revenue Forecast
Estimate
-0.00%
EBIT
Estimate
18.92%
Net Income
Estimate
--35.86%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets
Cadrenal Therapeutics, Inc. Common Stock
Wall Street analysts predict an average 1-year price target for CVKD of $32 , with forecasts ranging from a low of $32 to a high of $32 .
CVKD Lowest Price Target
Wall Street Target
32 USD
104.34%
CVKD Average Price Target
Wall Street Target
32 USD
104.34%
CVKD Highest Price Target
Wall Street Target
32 USD
104.34%
REVENUE FORECAST
Revenue Forecast Chart CVKD
EBIT FORECAST
EBIT Forecast Chart CVKD
NET INCOME FORECAST
Net Income Chart CVKD